Health Care Select Sector SPDR

Health Care Select Sector SPDR

Health Care Select Sector SPDR (XLV) is an exchange‑traded fund that provides diversified exposure to large-cap US health‑care companies across pharmaceuticals, biotechnology, medical devices, health‑care providers and insurers. It trades like a stock, offering a simple way to gain sector-specific exposure without selecting individual companies. Investors should note sector concentration risk — performance is tied to regulatory decisions, patent cycles, drug approvals and healthcare spending trends. XLV typically offers broad, liquid exposure and may distribute dividends, but yields and performance fluctuate. Fees for passive sector ETFs are generally low compared with active funds, though expenses reduce long‑term returns. Suitable for investors seeking targeted allocation to the health‑care sector within a diversified portfolio, XLV is not a substitute for personalised advice. This is general educational information only — values can fall as well as rise and past performance is not a reliable indicator of future results.

Stock Performance Snapshot

Below Average

Dividend

Health Care Select Sector SPDR's dividend yield of 1.59% is lower than many investors might prefer. If you invested $1000 you would be paid $15.90 a year in dividends (based on the last 12 months).

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring XLV

Fed Policy Shift Explained: Defensive Investment Guide

Fed Policy Shift Explained: Defensive Investment Guide

A recent warning from a top Federal Reserve official about a weakening U.S. job market suggests a cautious approach to future monetary policy. This pivot could create investment opportunities in defensive, high-quality companies that can better withstand economic uncertainty.

Published: October 5, 2025

Explore Basket

Why You’ll Want to Watch This Stock

📈

Sector exposure made easy

Gives broad access to large US health‑care names through one trade, though sector concentration means returns can diverge from the wider market.

Innovation and risk

Healthcare innovation (drugs, devices) can drive gains, but binary trial results and regulatory decisions can cause sharp moves.

🌍

Structural demand themes

An ageing population and rising healthcare spending support long‑term demand, yet policy and pricing pressures remain important risks.

Why invest with Nemo?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions